References
- Bartsch G, Frick J, Rüegg I, Bucher M, Holliger O, Oberholzer M, Rohr H P. Electron microscopic stereo‐logical analysis of the normal human prostate and of benign prostatic hyperplasia. J Urol 1979; 122: 481–486
- Bartsch G, Müller H R, Oberholzer M, Rohr H P. Light microscopic stereological analysis of the normal human prostate and of benign prostatic hyperplasia. J Urol 1979; 122: 487–491
- Caine M, Perlberg S, Meretyk S. A placebo‐controlled double‐blind study of the effect of phenoxybenzamine in benign prostatic obstruction. Br J Urol 1978; 50: 551–554
- Hedlund H, Anderson K ‐E. Ek A. Effects of prazosin in patients with benign prostatic obstruction. J Urol 1983; 130: 275–278
- Hedlund H, Anderson K ‐E, Larsson B. Alpha‐adrenoceptors and muscarinic receptors in the isolated human prostate. J Urol 1985; 134: 1291–1298
- Hedlund H, Anderson K ‐E. Effects of prazosin and carbachol in patients with benign prostatic obstruction. Scand J Urol Nephrol 1988; 22: 19–22
- Kirby R S, Coppinger S W C, Corcoran M O, Chapple C R, Flannigan M, Milroy E J G. Prazosin in the treatment of prostatic obstruction. A placebo‐controlled study. Br J Urol 1987; 60: 136–142
- Shapiro A, Mazouz B, Caine M. The alpha‐adrenergic blocking effect of prazosin on the human prostate. Urol Res 1981; 9: 17–20
- Whitfield H N, Doyle P T, Mayo M E, Poopalasingham N. The effect of adrenergic blocking drugs on outflow resistance. Br J Urol 1976; 47: 823–827